DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,304,026 | +2.1% | 186,635 | -1.3% | 5.96% | +11.3% |
| Q2 2023 | $45,367,542 | -7.1% | 189,031 | -2.5% | 5.35% | -12.1% |
| Q1 2023 | $48,843,666 | -6.5% | 193,793 | -1.5% | 6.09% | -7.8% |
| Q4 2022 | $52,231,795 | -0.9% | 196,789 | -3.6% | 6.60% | -2.1% |
| Q3 2022 | $52,717,000 | +1.3% | 204,101 | -0.6% | 6.75% | +13.4% |
| Q2 2022 | $52,047,000 | +17.9% | 205,299 | +36.4% | 5.95% | +53.6% |
| Q1 2022 | $44,147,000 | -11.5% | 150,503 | -0.8% | 3.87% | -3.0% |
| Q4 2021 | $49,905,000 | +8.0% | 151,682 | -0.1% | 3.99% | +3.2% |
| Q3 2021 | $46,226,000 | -2.8% | 151,838 | -14.3% | 3.87% | -1.4% |
| Q2 2021 | $47,546,000 | -21.0% | 177,172 | -33.7% | 3.92% | -26.8% |
| Q1 2021 | $60,181,000 | +2.1% | 267,376 | +0.8% | 5.36% | -1.8% |
| Q4 2020 | $58,950,000 | +0.1% | 265,375 | -3.0% | 5.46% | -13.9% |
| Q3 2020 | $58,905,000 | +32.6% | 273,557 | +8.9% | 6.34% | +23.3% |
| Q2 2020 | $44,432,000 | +42.3% | 251,272 | +11.4% | 5.14% | +13.0% |
| Q1 2020 | $31,224,000 | -6.7% | 225,594 | +3.5% | 4.55% | +17.6% |
| Q4 2019 | $33,454,000 | +6.8% | 217,968 | +0.5% | 3.87% | -0.1% |
| Q3 2019 | $31,324,000 | -2.1% | 216,883 | -3.1% | 3.87% | -2.8% |
| Q2 2019 | $31,980,000 | +23.6% | 223,761 | +14.2% | 3.98% | -9.1% |
| Q1 2019 | $25,865,000 | +9.6% | 195,913 | -14.4% | 4.38% | +6.9% |
| Q4 2018 | $23,603,000 | -7.6% | 228,887 | -2.6% | 4.10% | +29.6% |
| Q3 2018 | $25,531,000 | +11.5% | 234,960 | +1.3% | 3.16% | +3.1% |
| Q2 2018 | $22,893,000 | -3.5% | 231,993 | -4.2% | 3.07% | -0.4% |
| Q1 2018 | $23,715,000 | -33.1% | 242,210 | -36.6% | 3.08% | -8.6% |
| Q4 2017 | $35,457,000 | -12.9% | 381,997 | -19.5% | 3.37% | -7.7% |
| Q3 2017 | $40,723,000 | -25.7% | 474,742 | -26.9% | 3.65% | -26.1% |
| Q2 2017 | $54,810,000 | -16.6% | 649,489 | -15.4% | 4.94% | -6.3% |
| Q1 2017 | $65,682,000 | -19.0% | 767,936 | -26.3% | 5.27% | +6.3% |
| Q4 2016 | $81,090,000 | +24.2% | 1,041,756 | +25.1% | 4.96% | +85.9% |
| Q3 2016 | $65,284,000 | -35.6% | 832,804 | -17.0% | 2.67% | -22.4% |
| Q2 2016 | $101,360,000 | -32.1% | 1,003,565 | -36.2% | 3.44% | -24.0% |
| Q1 2016 | $149,202,000 | -5.3% | 1,572,864 | -7.3% | 4.52% | +7.1% |
| Q4 2015 | $157,509,000 | -27.0% | 1,695,835 | -33.0% | 4.22% | -19.8% |
| Q3 2015 | $215,687,000 | -5.9% | 2,531,241 | -5.5% | 5.26% | -2.3% |
| Q2 2015 | $229,145,000 | -3.5% | 2,677,239 | -4.3% | 5.39% | +4.6% |
| Q1 2015 | $237,570,000 | -10.0% | 2,798,234 | -9.1% | 5.15% | +2.0% |
| Q4 2014 | $263,982,000 | +4.8% | 3,079,939 | -7.1% | 5.05% | +6.2% |
| Q3 2014 | $251,882,000 | -6.7% | 3,315,110 | -3.3% | 4.75% | +0.7% |
| Q2 2014 | $269,962,000 | +701.9% | 3,428,966 | +663.9% | 4.72% | +705.3% |
| Q1 2014 | $33,665,000 | – | 448,870 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |